The global coronary artery bypass graft market size is expected to reach USD 24.06 billion by 2030, registering a CAGR of 9.2% over the forecast period, based on a new report by Grand View Research, Inc. The primary factor driving the industry is an increase in the prevalence of hypertension and cases of myocardial infarction. The American Heart Association estimated that in 2020, Coronary Heart Disease (CHD) was the leading cause of death in the U.S. In addition, the rising technological advancements have led to the development of endoscopic bypass surgery that offers various benefits compared to traditional bypass surgery. Such kind of advancements are contributing to the market growth. Furthermore, the rising geriatric population is influencing market growth.

Request a free sample copy or view the report summary: https://www.grandviewresearch.com/industry-analysis/coronary-artery-bypass-graft-cabg-market

The aged population is more prone to coronary artery blockages, and studies show that the average age of people undergoing Coronary Artery Bypass Graft (CABG) procedures is approximately older than 66 years. The COVID-19 pandemic had a negative impact on many industries and the CABG market was also highly affected. A study published by the University of Alabama at Birmingham shows an approximately 36% decline in patients undergoing bypass surgery. Many routine procedures were limited due to a workforce shortage. In addition, the supply of raw materials for the devices was limited in the initial phase of COVID-19. Thus, the above-mentioned factors lowered the manufacturing and production of devices.

Coronary Artery Bypass Graft Market Segmentation

  • The coronary artery bypass graft (CABG) market in the healthcare market size was estimated at USD 12.03 billion in 2022 and is expected to reach USD 24.06 billion in 2030
  • In 2022, North America dominated the global market and accounted for a revenue share of 47.5%. This growth can be attributed to a rise in cardiovascular cases across the region
  • By methods, the off-pump segment dominated the market and accounted for a revenue share of 53.8% in 2022. This growth can be attributed to various benefits associated with the product, such as small incisions, faster recovery, and shorter hospital stay
  • The single CABG surgery procedure segment dominated the industry and accounted for a revenue share of 32.7% in 2022. The segment also expected to grow at the fastest CAGR over the forecast period
  • The hospital end-use segment dominated the market and accounted for a revenue share of 52.8% in 2022

Coronary Artery Bypass Graft Market Segmentation

Grand View Research has segmented the global coronary artery bypass graft market based on method, procedure, end-use, and region:

Coronary Artery Bypass Graft Method Outlook (Revenue, USD Billion, 2018 - 2030)

  • Off-pump
  • On-pump
  • Minimally Invasive Direct

Coronary Artery Bypass Graft Procedure Outlook (Revenue, USD Billion, 2018 - 2030)

  • Single CABG Surgery
  • Double CABG Surgery
  • Triple CABG Surgery
  • Quadruple CABG Surgery

Coronary Artery Bypass Graft End-use Outlook (Revenue, USD Billion, 2018 - 2030)

  • Hospitals
  • Cardiology Centers
  • Others

List of Key Players in the Coronary Artery Bypass Graft Market

  • Medtronic
  • Terumo Corporation
  • Guidant Group
  • MAQUET Holding B.V. & Co.KG
  • Vitalitec International, Inc.
  • Novadaq Technologies Inc.
  • KARL STORZ GmbH & Co. KG
  • Edwards Lifesciences
  • Genesee Biomedical Inc.
  • Sorin Group

Browse the Full Report Here: https://www.grandviewresearch.com/industry-analysis/coronary-artery-bypass-graft-cabg-market